UTHR.NASDAQUnited Therapeutics CORP
Form 4: UNITED THERAPEUTICS CEO Sells Shares
Sentiment:
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on October 8, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $117.76 ($1,118,720) on October 8, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 200 Common Stock at $525.50 ($105,099) on October 8, 2026; holds 333,743 after (Indirect).
- Open-market sale: disposed of 767 Common Stock at $526.66 ($403,951) on October 8, 2026; holds 332,976 after (Indirect).
- Open-market sale: disposed of 273 Common Stock at $527.57 ($144,028) on October 8, 2026; holds 332,703 after (Indirect).
- Open-market sale: disposed of 200 Common Stock at $528.63 ($105,725) on October 8, 2026; holds 332,503 after (Indirect).
- Open-market sale: disposed of 199 Common Stock at $530.13 ($105,497) on October 8, 2026; holds 332,304 after (Indirect).
- Open-market sale: disposed of 1,061 Common Stock at $531.07 ($563,468) on October 8, 2026; holds 331,243 after (Indirect).
- Open-market sale: disposed of 600 Common Stock at $532.07 ($319,244) on October 8, 2026; holds 330,643 after (Indirect).
- Open-market sale: disposed of 800 Common Stock at $533.36 ($426,689) on October 8, 2026; holds 329,843 after (Indirect).
- Open-market sale: disposed of 920 Common Stock at $534.28 ($491,539) on October 8, 2026; holds 328,923 after (Indirect).
- Open-market sale: disposed of 480 Common Stock at $535.46 ($257,020) on October 8, 2026; holds 328,443 after (Indirect).
- Open-market sale: disposed of 824 Common Stock at $536.61 ($442,164) on October 8, 2026; holds 327,619 after (Indirect).
- Open-market sale: disposed of 1,016 Common Stock at $537.53 ($546,134) on October 8, 2026; holds 326,603 after (Indirect).
- Open-market sale: disposed of 605 Common Stock at $538.60 ($325,853) on October 8, 2026; holds 325,998 after (Indirect).
- Open-market sale: disposed of 1,091 Common Stock at $539.58 ($588,682) on October 8, 2026; holds 324,907 after (Indirect).
- Open-market sale: disposed of 424 Common Stock at $540.51 ($229,175) on October 8, 2026; holds 324,483 after (Indirect).
- Open-market sale: disposed of 40 Common Stock at $541.23 ($21,649) on October 8, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on October 8, 2026; holds 271,410 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $5,075,919 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-08 | Option exercise/conversion | Common Stock | 9,500 | $118 | $1.1M | 333,943 |
| 2026-10-08 | Open-market sale | Common Stock | 200 | $525 | $105.1K | 333,743 |
| 2026-10-08 | Open-market sale | Common Stock | 767 | $527 | $404.0K | 332,976 |
| 2026-10-08 | Open-market sale | Common Stock | 273 | $528 | $144.0K | 332,703 |
| 2026-10-08 | Open-market sale | Common Stock | 200 | $529 | $105.7K | 332,503 |
| 2026-10-08 | Open-market sale | Common Stock | 199 | $530 | $105.5K | 332,304 |
| 2026-10-08 | Open-market sale | Common Stock | 1,061 | $531 | $563.5K | 331,243 |
| 2026-10-08 | Open-market sale | Common Stock | 600 | $532 | $319.2K | 330,643 |
| 2026-10-08 | Open-market sale | Common Stock | 800 | $533 | $426.7K | 329,843 |
| 2026-10-08 | Open-market sale | Common Stock | 920 | $534 | $491.5K | 328,923 |
| 2026-10-08 | Open-market sale | Common Stock | 480 | $535 | $257.0K | 328,443 |
| 2026-10-08 | Open-market sale | Common Stock | 824 | $537 | $442.2K | 327,619 |
| 2026-10-08 | Open-market sale | Common Stock | 1,016 | $538 | $546.1K | 326,603 |
| 2026-10-08 | Open-market sale | Common Stock | 605 | $539 | $325.9K | 325,998 |
| 2026-10-08 | Open-market sale | Common Stock | 1,091 | $540 | $588.7K | 324,907 |
| 2026-10-08 | Open-market sale | Common Stock | 424 | $541 | $229.2K | 324,483 |
| 2026-10-08 | Open-market sale | Common Stock | 40 | $541 | $21.6K | 324,443 |
| 2026-10-08 | Option exercise/conversion | Stock Option | 9,500 | — | — | 271,410 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-08 | Option exercise/conversion (9,500 shares) |
| 2026-10-08 | Open-market sale (200 shares) |
| 2026-10-08 | Open-market sale (767 shares) |
| 2026-10-08 | Open-market sale (273 shares) |
| 2026-10-08 | Open-market sale (200 shares) |
| 2026-10-08 | Open-market sale (199 shares) |
| 2026-10-08 | Open-market sale (1,061 shares) |
| 2026-10-08 | Open-market sale (600 shares) |
| 2026-10-08 | Open-market sale (800 shares) |
| 2026-10-08 | Open-market sale (920 shares) |
| 2026-10-08 | Open-market sale (480 shares) |
| 2026-10-08 | Open-market sale (824 shares) |
| 2026-10-08 | Open-market sale (1,016 shares) |
| 2026-10-08 | Open-market sale (605 shares) |
| 2026-10-08 | Open-market sale (1,091 shares) |
| 2026-10-08 | Open-market sale (424 shares) |
| 2026-10-08 | Open-market sale (40 shares) |
| 2026-10-08 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.